Showing results (6201-6210 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|February 14, 2006
Neuroprotective therapies for Alzheimer's diseaseAnke Huber, Grant Stuchbury, Alexander Bürkle, et al.Current Pharmaceutical Design|February 14, 2006
Brain inflammation, cholesterol, and glutamate as interconnected participants in the pathology of Alzheimer's diseaseG E Ringheim, A M SzczepanikCurrent Pharmaceutical Design|February 14, 2006
Fatty acid amide hydrolase: a potential target for next generation therapeuticsMauro MaccarroneCurrent Pharmaceutical Design|November 19, 2016
A Review on Injury Mechanism of Intracerebral Hemorrhage in Vehicle AccidentsFan Li, Honggeng Li, Zhi Xiao, et al.Current Pharmaceutical Design|November 24, 2016
Therapeutic Suppression of Nonsense Mutation: An Emerging Target in Multiple Diseases and Thrombotic DisordersMd Asiful Islam, Fahmida Alam, Mohammad Amjad Kamal, et al.Current Pharmaceutical Design|November 24, 2016
Structural Modifications of Diarylpyrimidine-quinolone Hybrids as Potent HIV-1 NNRTIs with an Improved Drug Resistance ProfileTian-Qi Mao, Qiu-Qin He, Wen-Xue Chen, et al.Current Pharmaceutical Design|June 8, 2004
High throughput screening and characterization of HIV-1 entry inhibitors targeting gp41: theories and techniquesShuwen Liu, Shibo JiangCurrent Pharmaceutical Design|April 14, 2004
Structural and conformational aspects of the anticoagulant and anti-thrombotic activity of heparin and dermatan sulfateBenito Casu, Marco Guerrini, Giangiacomo TorriCurrent Pharmaceutical Design|April 14, 2004
Studies comparing low molecular weight heparin with heparin for the treatment of thromboembolism: a literature reviewH L Messmore, E Coyne, W H Wehrmacher, et al.Current Pharmaceutical Design|April 14, 2004
A systematic approach to simulating metabolism in computational toxicology. I. The TIMES heuristic modelling frameworkOvanes G Mekenyan, Sabcho D Dimitrov, Todor S Pavlov, et al.Pageof 1,008